Moneycontrol Presented by Motilal Oswal
Days hours minutes
Nerolac
Presented by :

Co-Presenting Sponsor :

Capital Trade

Powered by :

Godrej Properties

Associate Sponsors :

Aegon Life
LIC Housing Finance
Indiabulls
DHFL

Co-Presenting Sponsor

Capital Trade

Associate Sponsors

  • Indiabulls
  • Aegon Life
  • LIC Housing Finance
  • DHFL
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Aurobindo Pharm
Aurobindo Pharm
BSE: 524804NSE: AUROPHARMAISIN: INE406A01037

21st-Jan-2013 12:20Source: BSE

Aurobindo Pharm - Aurobindo Pharma receives final approvals for Oxacillin Injections

Aurobindo Pharma has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Oxacillin for Injection USP, packaged in 1g and 2g vials (ANDA 201539) and Oxacillin for Injection USP 10g/Vial Pharmacy Bulk Package (ANDA 201538). The products are ready for launch.

More Announcements on:

8th-Jan-2018 16:22Source: NSE

Aurobindo Pharma Limited

8th-Jan-2018 16:09Source: BSE

Aurobindo Pharma - Investor Presentation

27th-Dec-2017 12:19Source:

Aurobindo Pharma Limited

27th-Dec-2017 12:02Source: BSE

Aurobindo Pharma - Press Release / Media Release

18th-Dec-2017 13:41Source: BSE

Aurobindo Pharma - Clarifies on News item

18th-Dec-2017 12:44Source: NSE

Aurobindo Pharma Limited

16th-Dec-2017 18:17Source: BSE

Aurobindo Pharma - Change in Directorate

1 2 3 4 5 Next >>
Sections
Follow us on
Available On